Enrique Grande: Amazing review from Rana McKay and Neeraj Agarwal on the new PARPi + ARSIs combos

Enrique Grande posted on X about recent paper by Rana McKay et al., titled “First-line combination treatment with PARP and androgen receptor–signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in the United States.” published on Cancer Treatment Review.

“Amazing review from Rana McKay and Neeraj Agarwal on the new PARPi + ARSIs combos. Thanks for making the read very easy!!!!

First-line combination treatment with PARP and androgen receptor–signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in the United States.”

Source: Enrique Grande/X

Enrique Grande, MD, PhD, MSc, is an Associate Professor at Francisco de Vitoria University. He is also the Head of Oncology at MD Anderson Cancer Center. Dr. Grande specializes in researching genitourinary and endocrine tumors and actively collaborates in developing the Translational Research and Early Drug Development Unit.

He founded the Spanish Group for Research on Orphan and Uncommon Tumors (GETHI) and serves on the Directory Board of the Spanish Task Force Group for NETs (GETNE). Dr. Grande edits several international journals and has participated in recent neuroendocrine tumor trials that led to the approval of new drugs in this field.